September 14, 2026

FDA broadens APDS treatment options

An 8-patient study evaluated safety and pharmacokinetics in the younger pediatric population.

MDSpire News

August 28, 2026

FDA approves XFG-adapted COVID-19 vaccine

The 2026 to 2027 formulation aligns with FDA guidance on the preferred composition for COVID-19 vaccines beginning this fall.

MDSpire News

August 06, 2026

FDA Approves mRNA Flu Vaccine

The FDA based its approval for adults aged 50 to 64 years on phase 3 trial results, while use in adults aged 65 years and older received accelerated approval.

MDSpire News

August 03, 2026

Enzyme Disruption Could Impair Retinal Homeostasis

Preclinical models showed that impaired endolysosomal trafficking preceded photoreceptor degeneration and disrupted retinal pigment epithelial cell function.

MDSpire News